Setting out an ambitious strategy and ensuring it is implemented

The BIOASTER corporate governance consists of a Board of Directors and a Scientific Advisory Board.

Philippe Archinard

Philippe Archinard – President

Board of directors

LYONBIOPÔLE

Philippe ARCHINARD

President

LYONBIOPÔLE

Florence AGOSTINO-ETCHETTO

INSTITUT PASTEUR

François ROMANEUX

BIOMÉRIEUX

François LACOSTE

BOEHRINGER

Erick LELOUCHE

CNRS

Frédéric FAURE

CEA

Olivier Peyret

DANONE

Gérard DENARIAZ

INSERM

Claire GIRY

INSTITUT MÉRIEUX

Jean-Luc BELINGARD

SANOFI PASTEUR

Marie-José QUENTIN-MILLET

UNIVERSITÉ de LYON

En cours de désignation

SME

Florence SEJOURNE

SANOFI

Jacques VOLCKMANN

Marie-Danièle CAMPION
Rectrice de l’Académie de Lyon

LE MONDE VÉTÉRINAIRE

Emmanuelle SOUBEYRAN

LA METROPOLE DE LYON

David KIMELFELD

RÉGION AUVERGNE RHÔNE-ALPES

Laurent WAUQUIEZ

MEDICEN

En cours de nomination

Scientific advisory board

The board meets twice a year on BIOASTER premises.

Dr. Didier MAZEL (Institut Pasteur, Paris, France) is the chariman of the board.

Bioaster Board

Pr. ANDREMONT Antoine
Laboratoire de bactériologie
Hôpital Bichat-Claude Bernard, Paris, France

Pr. D’ACREMONT Valérie
Researcher chez SwissTPH, Switzerland

Pr. de WILDE Michel
Board member, Infectious Disease Research Institute, Seattle, USA

Dr. HEILMAN Carole

National Institute of Allergy and Infectious Diseases (NIAID)& National Institutes of Health (NIH), USA

Dr. KIENY Marie-Paule
Adjoint director WHO & INSERM, Paris, France

Dr. LOCHT Camille
Institut Pasteur de Lille, France

Pr. MAINARDI Jean-Luc
Hôpitaux Universitaires Paris Ouest, France

Dr. MERCENIER Annick
NutriLead, Switzerland

Pr. PANTALEO Giuseppe
Centre hospitalier Universitaire Vaudois, Lausanne (CHUV), Switzerland

Pr. SOKOL Harry
Hôpital Saint-Antoine, Paris, France

Dr. VIARI Alain
INRIA, France